Abbott Laboratories buy Piper Sandler
Start price
17.04.25
/
50%
€116.00
Target price
17.04.26
€127.60
Performance (%)
-18.42%
Price
13.03.26
€94.63
Summary
This prediction is currently active. The price of Abbott Laboratories has decreased since the start of the prediction. Compared to the start price this results in a performance of -18.42%. This prediction currently runs until 17.04.26. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | 0.767% | 0.767% |
| iShares Core DAX® | -1,10 % | -6,08 % |
| iShares Nasdaq 100 | 0,33 % | 2,33 % |
| iShares Nikkei 225® | -1,08 % | -7,99 % |
| iShares S&P 500 | -0,06 % | 0,88 % |
Comments by Piper_Sandler for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $145.00 price target on the stock, up previously from $133.00.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Piper_Sandler for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€93.02
23.01.26
23.01.26
€114.93
23.01.27
23.01.27
1.73%
13.03.26
13.03.26
Abbott Laboratories
Start price
Target price
Perf. (%)
€109.48
17.10.24
17.10.24
€122.61
17.10.25
17.10.25
0.46%
18.10.25
18.10.25
Abbott Laboratories
Start price
Target price
Perf. (%)
€103.70
19.09.24
19.09.24
€117.72
19.09.25
19.09.25
12.09%
20.09.25
20.09.25